Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1609-1612

  Geser, Nadine ^a   Stephan, Roger ^a   Korczak, Bozena M ^a   Beutin, Lothar ^b   Hächler, Herbert ^a  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 2; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; BETA LACTAMASE TEM 1; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; KANAMYCIN; POLYMYXIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SWITZERLAND;

ADULT; BETA-LACTAMASES; CARRIER STATE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GENETIC VARIATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION; SEROTYPING; SWITZERLAND;

EID: 84857154311     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05539-11     Document Type: Article

References (38)

1. Aarestrup FM, et al. 2006. First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production. J. Antimicrob. Chemother. 57:1258 -1259.
2. Ben-Ami R, et al. 2006. Influx of extended-spectrum β-lactamase- producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
3. Bonnet R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. (Pubitemid 38040170)
4. Brigante G, et al. 2005. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25:157-162. (Pubitemid 40138953)
5. Cantòn R, Coque TM. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
6. Clinical Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. CLSI, Wayne, PA.
7. Cortés P, et al. 2010. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76:2799-2805.
8. Duan RS, et al. 2006. Escherichia coli producing CTX-M β-lactamases in food animals in Hong Kong. Microb. Drug Resist. 12:145-148. (Pubitemid 44162807)
9. Eckert C, et al. 2004. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249-1255. (Pubitemid 38405479)
10. Eisner A, et al. 2006. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob. Agents Chemother. 50:785-787. (Pubitemid 43191002)
11. Fang H, Ataker F, Hedin G, Dornbusch K. 2008. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J. Clin. Microbiol. 46:707-712. (Pubitemid 351231321)
12. Filippini M, Masiero G, Moschetti K. 2006. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 78:77-92. (Pubitemid 44108323)
13. Geser N, et al. 2011. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in swine and cattle at slaughter in Switzerland. J. Food Prot. 74:446-449.
14. Girlich D, et al. 2007. Extended-spectrum β-lactamase CTX-M-1 in Escherichia coli in healthy poultry in France. Appl. Environ. Microbiol. 73:4681-4685. (Pubitemid 47122615)
15. Gniadkowski M. 2001. Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin. Microbiol. Infect. 7:597-608. (Pubitemid 34960356)
16. Gonçalves A, et al. 2010. Genetic characterization of extended-spectrum β-lactamases in Escherichia coli isolates of pigs from a Portuguese intensive swine farm. Foodborne Pathog. Dis. 7:1569-1573.
17. Hammad AM, Ahmed AM, Ishida Y, Shimamoto T. 2008. First characterization and emergence of SHV-60 in raw milk of a healthy cow in Japan. J. Vet. Med. Sci. 70:1269-1272.
18. Hernandez JR, Martinez-Martinez L, Cantón R, Coque TM, Pascual A. 2005. Spanish group for nosocomial infections (GEIH): nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49:2122-2125. (Pubitemid 40631637)
19. Jensen LB, Hasman H, Agersø Y, Emborg HD, Aarestrup FM. 2006. First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. J. Antimicrob. Chemother. 57:793-794.
20. Jouini A, et al. 2007. Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J. Antimicrob. Chemother. 60:1137-1141. (Pubitemid 47617766)
21. Kolár M, et al. 2010. Prevalence of ESBL-positive Enterobacteriaceae in large Moravian hospitals (Czech Republic). Klin. Mikrobiol. Infekc. Lek. 16:152-157. (In Czech.)
22. Lartigue MF, et al. 2007. Extended-spectrum β-lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51:2855-2860.
23. Lartigue MF, Fortineau N, Nordmann P. 2005. Spread of novel expanded-spectrum β-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. Clin. Microbiol. Infect. 11:588-591. (Pubitemid 40895163)
24. Leverstein-van Hall MA, et al. 2011. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2011.03497.x.
25. Luvsansharav UO, et al. 2011. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J. Infect. Chemother. doi:10.1007/s10156-011-0225-2.
26. Mesa RJ, et al. 2006. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). Antimicrob. Chemother. 58:211-215. (Pubitemid 44295011)
27. Meunier D, Jouy E, Lazizzera C, Kobisc M, Madec JY. 2006. CTX-M-1- and CTX-M-15-type β-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France. Int. J. Antimicrob. Agents 28:402-407. (Pubitemid 44636182)
28. Mora A, et al. 2011. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int. J. Antimicrob. Agents. 37:16-21.
29. CTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups. Antimicrob. Agents Chemother. 50:2741-2750.
30. Nüesch-Inderbinen MT, Hächler H, Kayser FH. 1996. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402. (Pubitemid 26181640)
31. Nüesch-Inderbinen MT, Kayser FH, Hächler H. 1997. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41:943-949. (Pubitemid 27194165)
32. Ørskov K, Ørskov I. 1984. Serotyping of Escherichia coli. Methods Microbiol. 14:43-122.
33. Pitout JD, et al. 1998. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:1350-1354. (Pubitemid 28257630)
34. Tängdén T, Cars O, Melhus A, Löwdin E. 2010. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother. 54:3564-3568.
35. Tian GB, et al. 2009. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum β-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog. Dis. 6:297-304.
36. Tian SF, Chen BY, Chu YZ, Wang S. 2008. Prevalence of rectal carriage of extended-spectrum β-lactamase-producing Escherichia coli among elderly people in community settings in China. Can. J. Microbiol. 54:781-785.
37. Tofteland S, et al. 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol. 45:199-205. (Pubitemid 46106427)
38. Woodford N, Fagan EJ, Ellington MJ. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154 -155.